When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment-Reference-Cited by-同舟云学术

When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

Published:2020-12 Issue: Volume:Volume 15 Page:3375-3384
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Cheng Wen-Chien^ORCID,Wu Biing-Ru^ORCID,Liao Wei-Chih,Chen Chih-Yu,Chen Wei-Chun^ORCID,Hsia Te-Chun^ORCID,Tu Chih-Yen,Chen Chia-Hung^ORCID,Hsu Wu-Huei

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference36 articles.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). Avaliable from: http://goldcopd.org/.Accessed January 2020.

2. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

3. FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

4. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study;Journal of Personalized Medicine;2021-12-07

2. Pulmonary embolism with chronic obstructive pulmonary disease;Chronic Diseases and Translational Medicine;2021-09

3. A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease;International Journal of Chronic Obstructive Pulmonary Disease;2021-06